Every recall we track for Amring Pharmaceuticals Inc — 1 in all — plus the complaints and injury reports the public filed about them.
Amring Pharmaceuticals recalls Lysteda 650mg tablets due to failed impurities tests. This may pose a risk of harmful substances. Affected lots X220317A and X2:20318A, expiring 09/25.